Aldeyra Therapeutics, Inc. Class Action Lawsuit
Company: Aldeyra Therapeutics, Inc.
Ticker: (NASDAQ) ALDX
Class Action Period: November 3, 2023 - March 16, 2026
See If You Qualify For Monetary Reward
Join the Aldeyra Therapeutics, Inc. Class Action Lawsuit
CLASS ACTION PERIOD
November 3, 2023 - March 16, 2026
Allegations
The complaint filed against Aldeyra Therapeutics, Inc. alleges the company made statements that were materially false and/or misleading and/or failed to disclose that: (1) The results of the reproxalap clinical trials were inconsistent; (2) the inconsistency of the results rendered any positive findings from these trials unreliable and not meaningful; and (3) as a result, defendants’ statements about Aldeyra’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
Eligibility
To join the lawsuit, you must have experienced a loss on Aldeyra Therapeutics, Inc. shares purchased within the class period specified above.
Lead Plaintiff Deadline
If you suffered a loss in Aldeyra Therapeutics, Inc. during the relevant time frame, you have until May 29, 2026 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Frequently Asked Questions
- How do I join the lawsuit against Aldeyra Therapeutics, Inc. (NASDAQ: ALDX)?
Investors who purchased shares of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) during the class period (November 3, 2023 - March 16, 2026) can join by submitting their transaction details through this case page.
- Ensure your purchase falls within the class period
- Provide basic transaction and loss details
- Submit your information before the deadline
The lead plaintiff deadline for this case is May 29, 2026, so investors should act quickly to protect their rights.
- Who is eligible for the Aldeyra Therapeutics, Inc. lawsuit?
Anyone who bought shares of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) during November 3, 2023 - March 16, 2026 and suffered financial losses may qualify.
- What is the lead plaintiff deadline to join the Aldeyra Therapeutics, Inc. case?
The lead plaintiff deadline for the Aldeyra Therapeutics, Inc. lawsuit is May 29, 2026. Investors should act quickly to avoid missing this deadline.
- What is the class period for Aldeyra Therapeutics, Inc.?
The class period for Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) is November 3, 2023 - March 16, 2026, during which investors may have been affected by alleged misconduct.
- Can I still join the Aldeyra Therapeutics, Inc. lawsuit if I sold my shares?
Yes. Investors who purchased Aldeyra Therapeutics, Inc. shares during November 3, 2023 - March 16, 2026 may still qualify, even if they sold their shares later.
- How much compensation can I receive from the Aldeyra Therapeutics, Inc. lawsuit?
Compensation depends on the total losses and the final settlement. Eligible investors in the Aldeyra Therapeutics, Inc. case may receive a portion of the recovery.
- Do I need to pay to participate in the Aldeyra Therapeutics, Inc. case?
No, most securities fraud cases involving Aldeyra Therapeutics, Inc. operate on a contingency basis, meaning there are no upfront costs unless there is a recovery.
- Will I need to appear in court for the Aldeyra Therapeutics, Inc. lawsuit?
In most cases, investors do not need to appear in court. The legal team manages the Aldeyra Therapeutics, Inc. case on behalf of participants.
- What documents are required for the Aldeyra Therapeutics, Inc. lawsuit?
To participate in the Aldeyra Therapeutics, Inc. lawsuit, investors may need to provide transaction records, purchase dates, number of shares, and loss details.
- What happens after I submit my trade information for Aldeyra Therapeutics, Inc.?
After submission, your details for the Aldeyra Therapeutics, Inc. case will be reviewed, and you may be contacted regarding eligibility or next steps.
- Is this legal advice for the Aldeyra Therapeutics, Inc. lawsuit?
No, this page provides information about the Aldeyra Therapeutics, Inc. case and does not constitute legal advice or create an attorney-client relationship.
- Why should I act quickly on the Aldeyra Therapeutics, Inc. case?
The lead plaintiff deadline for the Aldeyra Therapeutics, Inc. lawsuit is May 29, 2026. If you are an investor, you may have the opportunity to seek appointment as lead plaintiff or remain an absent class member.
EXPLORE MORE CASES
Driven Brands Holdings Inc.
DRVN
Lead Plaintiff Deadline: May 8, 2026
Class Period: May 9, 2023 - February 24, 2026
Lakeland Industries, Inc.
LAKE
Lead Plaintiff Deadline: April 24, 2026
Class Period: December 1, 2023 - December 9, 2025